Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

A variety of bacterial infections have been tackled by glycoconjugates over the recent years, and more vaccines are either under development at preclinical level or in clinical trials. So far, licensed glycoconjugate vaccines have made use of capsular polysaccharides or derived fragments. Today, many glycoconjugates are making use of other classes of sugars, in particular, the O-antigen portion of lipopolysaccharide molecules. Here, we report a simplified method for O-antigen extraction and purification that avoids the step of lipopolysaccharide isolation. Also, a selective chemistry for terminal linkage of O-antigen chains to a carrier protein is described, together with analytical methods for intermediates and final conjugate characterization.

Citation

Francesca Micoli, Carlo Giannelli, Roberta Di Benedetto. O-Antigen Extraction, Purification, and Chemical Conjugation to a Carrier Protein. Methods in molecular biology (Clifton, N.J.). 2021;2183:267-304

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 32959249

View Full Text